Astrana Health, Inc.
ASTH
$30.37
-$1.03-3.28%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -28.93% | 39.93% | 49.52% | 40.15% | 34.42% |
Total Depreciation and Amortization | 57.35% | 46.09% | 25.26% | 6.25% | 1.17% |
Total Amortization of Deferred Charges | 72.29% | 82.05% | 60.17% | 36.53% | 12.99% |
Total Other Non-Cash Items | 254.93% | -63.77% | 0.75% | -37.69% | -40.83% |
Change in Net Operating Assets | -171.99% | -142.71% | -56,674.39% | -71.28% | -1,096.32% |
Cash from Operations | -23.49% | -38.41% | -22.67% | 1.02% | -16.93% |
Capital Expenditure | 71.85% | 43.84% | 33.06% | 30.81% | -24.36% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -2,146.01% | -661.30% | -701.95% | -272.31% | 60.18% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -25.00% | -1,199.49% | -373.12% | -249.92% | -194.73% |
Cash from Investing | -193.63% | -316.92% | -1,298.45% | -8,510.47% | -821.17% |
Total Debt Issued | -39.59% | 9,420.12% | 10,965.03% | 8,644.94% | 7,807.92% |
Total Debt Repaid | 86.51% | -17,320.62% | -4,641.18% | -4,497.53% | -4,539.77% |
Issuance of Common Stock | -32.59% | -89.66% | -96.82% | -96.88% | -83.15% |
Repurchase of Common Stock | 45.06% | 46.38% | 56.35% | 96.56% | -5.64% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -1,552.15% | -342.44% | -342.44% | -342.44% |
Other Financing Activities | 11.23% | -1,685.35% | -181.57% | -43.24% | -8.59% |
Cash from Financing | 3,850.48% | 6,112.81% | 2,055.53% | 521.67% | 117.03% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -182.47% | -17.63% | -47.22% | 65.87% | -88.85% |